Taysha Gene Therapies, Inc. (TSHA)

NASDAQ: TSHA · Real-Time Price · USD

4.370

+0.060 (1.39%)

At close: Apr 2, 2026, 4:00 PM EDT

4.450

+0.080 (1.83%)

After-hours: Apr 2, 2026, 7:49 PM EDT

Taysha Gene Therapies Employees

Taysha Gene Therapies had 99 employees as of December 31, 2025. The number of employees increased by 26 or 35.62% compared to the previous year.

Employees

Change (1Y)

Growth (1Y)

35.62%

Revenue / Employee

$98,717

Profits / Employee

-$1,100,960

Market Cap

1.26B

Employees Chart

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	99	26	35.62%
Dec 31, 2024	73	21	40.38%
Dec 31, 2023	52	-13	-20.00%
Dec 31, 2022	65	-113	-63.48%
Dec 31, 2021	178	140	368.42%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro

Company Name	Employees
Novavax	749
Immatics	711
Pharming Group	404
Wave Life Sciences	317
Zenas BioPharma	167
Olema Pharmaceuticals	131
MoonLake Immunotherapeutics	130
DBV Technologies	117